Prevalence of Diabetic Retinopathy and the Experience of Using Sulodexide in Comprehensive Treatment

Various therapeutic approaches are used in the management of DR, among which integrated treatment strategies play a crucial role. These are aimed not only at glycemic control but also at improving microcirculation and stabilizing the retinal vascular wall. Sulodexide, a drug with proven angioprotective and anticoagulant properties, has demonstrated efficacy in the treatment of a range of vascular pathologies, including diabetic complications. Clinical studies indicate that sulodexide, when used as part of combination therapy for diabetic retinopathy, contributes to improved microcirculatory function and slows the progression of retinal damage. This article presents an analysis of the prevalence of diabetic retinopathy and an evaluation of the clinical experience of using sulodexide in combination therapy, reflecting current trends in the management of this condition. Special emphasis is placed on epidemiological data and treatment outcomes, highlighting the importance of a comprehensive approach in reducing the risk of severe complications and improving the quality of life for patients with diabetic retinopathy.